2026-04-02-A-share Market Review: 20260402 In-depth Analysis

{
    "title": "Market Divergence Intensifies with Increased Volume, High-flying Tech Stocks Face Selling Pressure, Can Cyclical Resources Take Over?",
    "tags": ["Market Divergence", "High-level Correction", "Cyclical Stocks", "Sentiment Cooling", "Capital Rotation"],
    "content": "## 🚩 Market Sentiment Diagnosis\n\nToday, the A-share market generally presented a high-level divergence with increased trading volume and a corrective trend. The Shanghai Composite Index fell by 0.74%. While the decline was not substantial, the widespread downward trend across the market was evident, with an Advance/Decline Ratio of 1052/4377, indicating significantly more declining stocks than advancing ones.\n\nThe total market turnover reached CNY 1,842.95 billion, a relatively high level. However, given the declining index and widespread stock depreciation, this suggests increased profit-taking and divergence rather than a consensus bullish outlook.\n\nThere were 28 Limit-up stocks, 5 Limit-down stocks, and 18 unsealed Limit-up stocks. The relatively low number of Limit-up stocks, coupled with a high unsealed Limit-up rate of approximately 39.13% (18 / (28 + 18)), indicates weak investor willingness to chase rallies and hesitation in pushing stocks to Limit-up. This points to significant intraday divergence. Profit-making opportunities were concentrated in a few consecutive Limit-up stocks and specific themes, but their sustainability faces severe challenges. Conversely, losses were widespread across most declining stocks, particularly in previously popular high-valuation stocks.\n\nThe current market phase can be characterized as 'high-level divergence with volume-driven correction.' Profit-making opportunities are primarily found in a few oversold rebound stocks or those with independent catalysts, while losses reflect a lack of buying support at previous highs, suggesting that risk release is not yet complete.\n\n## 💰 Core Themes & Capital Flows\n\nBased on the [Top 20 Stocks by Turnover], capital is visibly withdrawing from previously hot technology growth sectors (such as optical modules, AI, new energy, etc.). Major technology and new energy stocks like Sungrow Power Supply, Zhongji Innolight, E-SUN, T&F Communications, and CATL all experienced varying degrees of decline, with their turnover ranking among the highest, indicating significant capital outflow.\n\nAmidst the overall correction, certain cyclical sectors and specific concept stocks garnered capital interest:\n\n-   **Hot Sectors**: The [Resource Extraction Concept] sector led with a +3.12% increase, with stocks like Baker Hughes and CPECC hitting Limit-up, indicating capital's demand for risk aversion and allocation in upstream resources. Additionally, the [SPD Concept] also showed some performance, but it was not a primary theme.\n-   **Broad-based Resilience Sectors**: The current market lacks obvious 'broad-based resilience sectors.' Capital is tending towards caution, primarily focusing on localized plays in individual stocks with clear positive catalysts or short-term drivers. The market style leans towards 'theme speculation' and 'rotational gains,' rather than a broad rally driven by large-cap stocks.\n\nAmong the top 20 by turnover, China Merchants Energy Shipping (+8.17%) and YOFC (+7.95%) showed strong performance but both experienced unsealed Limit-ups, indicating significant capital divergence. Ganfeng Lithium's (+3.39%) rise also confirmed localized heat in resource stocks.\n\n## 🪜 Consecutive Limit-up Ladder & Space Play\n\n**Highest Board (Space Board)**: Tianjin Pharmaceutical (600488) became the focal point of market sentiment with a 5-day 5-Limit-up streak, belonging to the Chemical Pharmaceutical industry. It broke through the market sentiment high, but whether it can continue to drive its sector still needs observation.\n\n**Consecutive Limit-up Ladder**:\n-   5 Limit-ups: Tianjin Pharmaceutical (Chemical Pharmaceutical)\n-   3 Limit-ups: Xinzg Port (Electric Power), Xinghui Environmental (Plastics), Tongda Group (Power Grid Equipment)\n-   2 Limit-ups: Beida Pharmaceutical (Chemical Pharmaceutical), Yibai Pharmaceutical (Traditional Chinese Medicine)\n\nThe consecutive Limit-up stocks are spread across various themes, including pharmaceuticals, electric power, and traditional manufacturing, indicating a lack of clear, large-scale consensus main themes in the current market. Instead, capital is largely rotating and establishing positions within different smaller themes.\n\n**Unsealed Limit-up Signal**: 18 stocks experienced unsealed Limit-ups, a high rate that clearly signals a deceleration of market sentiment at high levels and increasing divergence. Notably, high-flying stock Minor Pharma (10-day 6-Limit-up streak, +6.36%) unsealed its Limit-up, warning that risks in high-sentiment stocks are accelerating their release, with significant risks for chasing rallies or taking over positions. High-turnover stocks like China Merchants Energy Shipping and YOFC also unsealed their Limit-ups, reflecting capital's hesitation and short-term profit-taking pressure. However, their significant intraday gains suggest active buying support from some capital, indicating a healthy divergence rather than panic selling.\n\n## ⚡ Key Movers Analysis\n\n1.  **Tianjin Pharmaceutical (600488)**: 5-day 5-Limit-up streak, Chemical Pharmaceutical. As the market's highest board, its strong performance logic may stem from an oversold rebound and the appeal of low-priced stocks, coupled with localized attention on the pharmaceutical sector. When overall market sentiment is not high, the demonstration effect of low-priced consecutive Limit-up stocks can be more pronounced, but their purely sentiment-driven nature also implies accumulating risk.\n\n2.  **Tongda Group (002560)**: 3-day 3-Limit-up streak, Power Grid Equipment. With a turnover of CNY 2.709 billion and a turnover rate of 46.58%, it shows that this stock is a focal point of intense capital speculation. Multiple unsealed Limit-ups followed by re-sealing demonstrate the resilience of bullish capital, but high turnover also implies rapid share exchange, leading to significant uncertainty in future trends. Its logic may be related to policies or order expectations in the electric power and power grid equipment sectors.\n\n3.  **China Merchants Energy Shipping (601872)**: +8.17%, turnover of CNY 6.428 billion. Shipping and Port sector, driven by macro factors such as global commodity trade recovery and expectations of rising freight rates. Although it unsealed its Limit-up 8 times today, the massive turnover and high percentage increase indicate significant capital expectations for an improvement in the sector's prosperity. Short-term divergence does not alter the long-term logic.\n\n4.  **CPECC (600339)**: First Limit-up, +10.12%, turnover of CNY 0.929 billion, belonging to the Resource Extraction Concept. Against the backdrop of overall strength in resource stocks today, its Limit-up may benefit from international crude oil price fluctuations or expectations for demand in upstream oilfield services engineering. This is a typical example of capital shifting from previous highs to cyclical lows, possessing a certain degree of sector linkage effect.\n\n## 🧭 Next-Day Trading Strategy Recommendations\n\nThe current market is in a high-level divergence and correction phase. Operations should remain cautious, with 'observe more, act less, control positions' as the main principle.\n\n**Observation Points for Tomorrow**:\n\n1.  **Resource Extraction Concept**: Having performed strongly today, observe whether there are new low-level catch-up opportunities within the sector, or if core varieties can initiate a second wave of gains. However, be wary of chasing rallies; waiting for a pullback and stabilization is a safer option.\n2.  **High-Turnover Unsealed Limit-up Stocks from Today**: For stocks like China Merchants Energy Shipping and YOFC, if they can quickly stabilize and achieve a 'reversal package' (rebound to close higher than previous high), it indicates strong buying support and capital's optimism about their underlying logic. If they continue to fall, be alert to short-term risks.\n3.  **Height of Consecutive Limit-up Stocks**: Whether Tianjin Pharmaceutical can continue to extend its upward space, and whether other low-level consecutive Limit-up stocks can advance, are important indicators for observing market sentiment and buying support.\n4.  **Total Market Trading Volume**: Observe whether trading volume continues at high levels. If it consistently shrinks, market correction pressure might ease; if it continues to increase on declines, be wary of systemic risks.\n\n**Operational Tone**: Take profits on some high-position stocks when opportunities arise. For sectors and individual stocks with clear logical support that have corrected to appropriate levels, moderate attention can be given, but heavy positions are not advisable. Overall, prioritize defense.\n\n**Key Stock Operation Suggestions**:\n\n-   **Tianjin Pharmaceutical, Tongda Group**: High-sentiment, high-position stocks like these carry significant risk; chasing rallies is not recommended. It is advisable to observe and wait for full correction or new opportunities after market sentiment recovers.\n-   **China Merchants Energy Shipping, CPECC**: If they can stabilize and maintain strength tomorrow, or experience a short-term pullback, they can be considered for attention. However, in the current market environment, blindly establishing positions is not recommended. Consider partial exploratory allocation or continued observation.\n-   **Previous High-flying Tech Stocks**: Such as optical modules, AI, new energy, etc., already experienced selling pressure today. Be wary of further decline risks tomorrow; intervention is not recommended.\n\n---\nNote:\n1. Data Source: AKShare.\n2. This article is AI-assisted and aims to provide market insights and data analysis, not investment advice.\n3. Disclaimer: Investment carries risks; entry into the market must be cautious. The content of this article is for reference only and does not constitute any investment advice or recommendation. Please make independent judgments based on your own circumstances.\n"
}